Johnson & Johnson to Separate Orthopedics Unit
Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences industry.
In corporate restructuring news, Johnson & Johnson has announced plans to separate its orthopedics business into an independent company.
Other key topics include the global implications of the Most Favored Nation drug pricing proposal and strategies for small biotechs to reach market faster.
No specific quotes are available in the given text.
Author's summary: Johnson & Johnson separates orthopedics unit.
More News
- Solomon Named Big South Preseason Player of the Year; Bulldogs Picked Second in Preseason
- Who won fashion month SS26 on social media?
- Wilson is wrong about women’s rights and the 19th Amendment
- Mateusz Gamrot Releases His First Statement Following His Loss To Charles Oliveira
- Uncovering untold stories: Finding Lucinda » Sandpoint Reader
- Who knew that the public would end up supporting striking teachers? Not Danielle Smith and the UCP! - Alberta Politics
- Lilley: Is Carney ready to surrender Canada's auto industry?
- Electric Island Expands with Five Shows and a Massive Lineup
- Why the Reckoning Is a Historian's Protest - CEOWORLD magazine
- In pics: The iconic Victoria's Secret Fashion Show returns – Emirates Woman